Dextromethorphan and guaifenesin use should be monitored diligently in patients with "inadequate metabolizer" CYP2D6 enzyme ranges and patients that are sedated. This combination medication has a substantial median toxic dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these sufferers. Dextromethorphan and guaifenesin may cause neonatal gasping https://apple-vision-pro-for-sale18406.dailyblogzz.com/30672711/dextromethorphan-dxm-for-sale-an-overview